The clinical course of CLL is quite heterogeneous, ranging from a fairly asymptomatic ailment which will even regress spontaneously to some progressive illness that sooner or later brings about the patient’s Loss of life, so there has often been remarkable fascination in identifying the prognosis of unique sufferers. Even though lots of prognosti